Format
Sort by
Items per page

Send to

Choose Destination

Best matches for HUMAN RHO(D) IMMUNE GLOBULIN/PD:

Potential drug interaction between Rho(D) immune globulin and live virus vaccine. Holmes A et al. Nurs Womens Health. (2014)

Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy. Aitken SL et al. Am J Health Syst Pharm. (2015)

Dermatofibrosarcoma protuberans arising at a Rho(D) immune globulin injection site. Hirano SA et al. Cutis. (2012)

Search results

Items: 1 to 20 of 435

1.

Nonhemolytic passenger lymphocyte syndrome.

Sandler SG, Han S, Langeberg A, Matsumoto C, Fishbein TM.

Transfusion. 2017 Dec;57(12):2942-2945. doi: 10.1111/trf.14383. Epub 2017 Oct 26.

PMID:
29076164
2.

[Clinical effect of anti-D immunoglobulin in treatment of childhood immune thrombocytopenia: a Meta analysis].

Qin W, Huang SL, Li TT.

Zhongguo Dang Dai Er Ke Za Zhi. 2017 Oct;19(10):1070-1076. Chinese.

PMID:
29046203
3.

A Guide to Terminology for Rh Immunoprophylaxis.

Sandler SG, Queenan JT.

Obstet Gynecol. 2017 Sep;130(3):633-635. doi: 10.1097/AOG.0000000000002190.

PMID:
28796682
4.

Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.

Committee on Practice Bulletins-Obstetrics.

Obstet Gynecol. 2017 Aug;130(2):e57-e70. doi: 10.1097/AOG.0000000000002232.

PMID:
28742673
5.

Practice Bulletin No. 181 Summary: Prevention of Rh D Alloimmunization.

[No authors listed]

Obstet Gynecol. 2017 Aug;130(2):481-483. doi: 10.1097/AOG.0000000000002226.

PMID:
28742667
6.

Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.

Quantock KM, Lopez GH, Hyland CA, Liew YW, Flower RL, Niemann FJ, Joyce A.

Transfusion. 2017 Aug;57(8):1938-1943. doi: 10.1111/trf.14156. Epub 2017 Jun 21.

PMID:
28639307
7.

Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.

Esquivel A, Busse WW, Calatroni A, Togias AG, Grindle KG, Bochkov YA, Gruchalla RS, Kattan M, Kercsmar CM, Khurana Hershey G, Kim H, Lebeau P, Liu AH, Szefler SJ, Teach SJ, West JB, Wildfire J, Pongracic JA, Gern JE.

Am J Respir Crit Care Med. 2017 Oct 15;196(8):985-992. doi: 10.1164/rccm.201701-0120OC.

PMID:
28608756
8.

Persistent hemolytic disease of the fetus and newborn (HDFN) associated with passive acquisition of anti-D in maternal breast milk.

Li M, Blaustein JC.

Transfusion. 2017 Sep;57(9):2121-2124. doi: 10.1111/trf.14171. Epub 2017 Jun 5.

PMID:
28580721
9.

Can serological methods help distinguish between prophylactic and alloimmune anti-D?

Irving C, Crennan M, Vanniasinkam T.

Transfus Med. 2017 Oct;27 Suppl 5:362-368. doi: 10.1111/tme.12420. Epub 2017 May 15.

PMID:
28508562
10.

A review of maternal alloimmunisation to Rh D in Northern Ireland.

McCauley CJ, Morris K, Maguire K.

Transfus Med. 2017 Apr;27(2):132-135. doi: 10.1111/tme.12387. Epub 2017 Jan 19.

PMID:
28101958
11.

[RhD alloimmunization in pregnant women in Rio de Janeiro State, Brazil: perspectives and challenges].

Beserra AH, Artmann E, Santos MC.

Cad Saude Publica. 2016 Nov 1;32(11):e00005516. doi: 10.1590/0102-311X00005516. Portuguese.

12.

Laboratory management of perinatal patients with apparently "new" anti-D.

Hannon JL, Clarke G.

Immunohematology. 2016 Sep;32(3):108-111.

PMID:
27834484
13.

Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.

de Haas M, Thurik FF, van der Ploeg CP, Veldhuisen B, Hirschberg H, Soussan AA, Woortmeijer H, Abbink F, Page-Christiaens GC, Scheffer PG, Ellen van der Schoot C.

BMJ. 2016 Nov 7;355:i5789. doi: 10.1136/bmj.i5789.

14.

Pathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement.

Welsh KJ, Bai Y; Education Committee of the Academy of Clinical Laboratory Physicians and Scientists.

Am J Clin Pathol. 2016 Jun;145(6):744-51. doi: 10.1093/ajcp/aqw051. Epub 2016 Jun 6. Review.

PMID:
27267375
15.

RhD immunisation in pregnancy.

Akkök ÇA, Eggebø TM, Kiserud T, Heier HE.

Tidsskr Nor Laegeforen. 2016 May 3;136(8):724-6. doi: 10.4045/tidsskr.15.0684. eCollection 2016 May. English, Norwegian. No abstract available.

16.

Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study.

Eghbali A, Azadmanesh P, Bagheri B, Taherahmadi H, Sadeghi Sedeh B.

Fundam Clin Pharmacol. 2016 Aug;30(4):385-9. doi: 10.1111/fcp.12198. Epub 2016 Apr 6.

PMID:
26991138
17.

Platelet transfusion and respecting patient D type.

Cid J, Yazer MH, Lozano M.

Curr Opin Hematol. 2015 Nov;22(6):540-6. doi: 10.1097/MOH.0000000000000185. Review.

PMID:
26414185
18.
19.

Rhesus Immune Globulin Dosing in the Obesity Epidemic Era.

Pham HP, Marques MB, Williams LA 3rd.

Arch Pathol Lab Med. 2015 Sep;139(9):1084. doi: 10.5858/arpa.2014-0605-LE. No abstract available.

PMID:
26317451
20.

Should cell-free DNA testing be used to target antenatal rhesus immune globulin administration?

Ma KK, Rodriguez MI, Cheng YW, Norton ME, Caughey AB.

J Matern Fetal Neonatal Med. 2016;29(11):1866-70. doi: 10.3109/14767058.2015.1066773. Epub 2015 Aug 13.

PMID:
26169705

Supplemental Content

Loading ...
Support Center